FBIO Stock Analysis: Buy, Sell, or Hold?
FBIO - Fortress Biotech, Inc.
$3.10
-0.26 (-7.74%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Smart Money Accumulation
FBIO is down 8.8% this week, but smart money is accumulating calls. Top strike: $2.5 2026-04-17 with 3,179 OI. Call ratio: 90% View Scanner →
Strength: 8.4/10
Get Alerted When FBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called FBIO this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: FBIO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: FBIO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: FBIO is currently trading at $3.10, which is considered oversold relative to its 30-day fair value range of $3.34 to $4.08. From a valuation perspective, the stock is trading at a discount (Forward PE: 310.0) compared to its historical average (346.0). Remarkably, the market is currently pricing in an annual earnings decline of 3.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, FBIO is in a uptrend. The price is currently testing key support at $3.10. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (21th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.75 (+246.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, FBIO is in a uptrend. The price is currently testing key support at $3.10. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (21th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.75 (+246.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$3.34 -
$4.08
Company Quality Score
54/100
(HOLD)
Options IV Signal
21th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
79.6%
Protect Your Profits
Holding FBIO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 21th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.7%)
- BULLISH: Trading 246.8% below Wall St target ($10.75)
- CAUTION: Recommendation downgraded due to -8.8% 5-day decline
Fair Price Analysis
30-Day Fair Range
$3.34 -
$4.08
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.42
(13.4%)
Support & Resistance Levels
Support Level
$3.10
Resistance Level
$3.79
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
310.00
Wall Street Target
$10.75
(+246.8%)
Revenue Growth (YoY)
20.5%
Profit Margin
6.4%
Valuation Discount vs History
-3.6% cheaper
PE vs Historical
310.0 vs 346.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.6%
(market-implied from PE analysis)
1-Year Target
$2.99
(-4%)
2-Year Target
$2.88
(-7%)
3-Year Target
$2.78
(-10%)
3-Yr Target (if PE normalizes)
(PE: 310→346)
$3.10
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 310.0, Growth: -96.8%)
$2.26
(+-27%)
Base:
(SPY PE: 22.3, Growth: -96.8%)
$0.16
(-95%)
Bear:
(PE: 19.0, Growth: -96.8%)
$0.14
(-96%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 310.0 to 346.0
Stabilization Target:
$3.46
(+11.6%)
PE Expansion Potential:
+11.6%
Last updated: February 01, 2026 4:49 AM ET
Data refreshes hourly during market hours. Next update: 5:49 AM
Data refreshes hourly during market hours. Next update: 5:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
Advanced FBIO Option Strategies
Professional options setups generated by AI based on today's FBIO price and gamma walls.
